Quinoxalines derivatives and pharmaceutical compositions and kits

US8895559B2 · kind B2 · utility

Assignee

• Merck Patent GmbH · DE

Inventors

• Markus Klein · Weiterstadt, DE
• Ulrich Emde · Darmstadt, DE
• Hans-Peter Buchstaller · Griesheim, DE
• Christina Esdar · Darmstadt, DE
• Oliver Poeschke · Wiesbaden, DE

Key dates

• Filing date: Sep 22, 2011
• Grant date: Nov 25, 2014
• Expiry date: Sep 22, 2031

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D417/14
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

A variety of specific compounds within the scope of formula Iwhich are useful as PI3K inhibitors and can be employed for the treatment of autoimmune diseases, inflammation, cardiovascular diseases, neurodegenerative diseases and tumours, and pharmaceutical compositions and kits containing said specific compounds.